Immunoenhancement Effects of Glycosaminoglycan from Apostichopus Japonicus: In Vitro and In Cyclophosphamide-Induced Immunosuppressed Mice Studies
Overview
Pharmacology
Affiliations
In this study, the immunomodulatory activities of glycosaminoglycan (AHG) on the nature killer (NK) cells, cytotoxic T lymphocytes (CTLs) and cyclophosphamide (CY)-treated mice were investigated. After stimulation with multiple concentrations of AHG (0-100 μg/mL), NK cells and CTLs displayed outperformance against YAC-1 and B16 cells, respectively. Furthermore, the mitogen-induced splenic lymphocyte proliferation in CY-induced immunosuppressed mice was significantly promoted by AHG. In addition, the administration of AHG dramatically increased the splenocytes Ca concentration and the delayed-type hypersensitivity (DTH) reaction in a dose-dependent manner. Besides, AHG could strongly increase the total antioxidant capacity (T-AOC), the activities of superoxidase dismutase (SOD), catalase (CAT) as well as glutathione peroxidase (GSH-PX), and could decrease the malondialdehyde (MDA) level in the heart, kidney and liver. These findings indicated that AHG played an important role in the immune enhancement and protection against CY-induced immunosuppression and oxidative damage. Our findings provide experimental evidence for further research and possible immunostimulatory applications of AHG in clinical practice.
Yan C, Qu H, Li X, Feng B Int J Mol Sci. 2023; 24(16).
PMID: 37628768 PMC: 10454611. DOI: 10.3390/ijms241612583.
Cui E, Tang P, Zhu X, Lv M, Wang S, Xue Y Foods. 2023; 12(5).
PMID: 36900578 PMC: 10001223. DOI: 10.3390/foods12051062.
Nam J, Choi J, Monmai C, Rod-In W, Jang A, You S J Microbiol Biotechnol. 2021; 32(2):256-262.
PMID: 34949747 PMC: 9628850. DOI: 10.4014/jmb.2110.10021.
Dai J, Chen J, Qi J, Ding M, Liu W, Shao T Food Sci Nutr. 2021; 9(2):728-735.
PMID: 33598158 PMC: 7866624. DOI: 10.1002/fsn3.2038.
Niu Y, Dong J, Jiang H, Wang J, Liu Z, Ma C Oxid Med Cell Longev. 2020; 2020:1603735.
PMID: 32256944 PMC: 7091559. DOI: 10.1155/2020/1603735.